NFKB1 and neoplasm: And cisplatin and doxorubicin induced ATC cell death were synergistically promoted by silencing ATC stem cell markers [31]; Intervention of JAK/STAT3 and NF-κB signals in ATC CSCs could effectively impede tumor growth in vivo [32].